About AVT
Browse Articles
Authors
Customer Services

Browse Articles

Additional files for manuscripts published before Volume 14 Issue 6 can be found via the abstract link.

Articles published electronically ahead of print and our archive from Volume 4 Issue 1 to Volume 21 Issue 5 can be found below. Articles published earlier will be made available as soon as possible. If you require an article that cannot be found below, please contact the Editorial Office.

Currently showing:   
Displaying 2023 results:

Free
Correction

Correction: Effect of drug resistance mutations on antiviral agents in HCV patients

Grey Liu, Qingxian Cai, Zhanyi Li, Xiaoqiong Shao, Qiumin Luo, Xiaohong Zhang, Zhixin Zhao

Antiviral Therapy 2016; 21:467


Free
Addendum

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

Marianne Martinello, Margaret Hellard, David Shaw, Kathy Petoumenos, Tanya Applegate, Jason Grebely, Barbara Yeung, Laurence Maire, David Iser, Andrew Lloyd, Alexander Thompson, Joe Sasadeusz, Paul Haber, Gregory J Dore, Gail V Matthews

Antiviral Therapy 2016; 21:465


Case report

Cerebrospinal fluid viral escape and acute encephalitis in a patient on boosted protease inhibitor monotherapy

Juan Tiraboschi, Lisa Hamzah, Ata Siddiqui, Ranjababu Kulasegaram, Frank Post, Julie Fox

Antiviral Therapy 2016; 21:461-464


Case report

Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome

Uh Jin Kim, Eun-Jeong Won, Seung-Jung Kee, Sook-In Jung, Hee-Chang Jang

Antiviral Therapy 2016; 21:455-459


Short communication

Naturally occurring HCV NS5A/B inhibitor resistance-associated mutations to direct-acting antivirals

Linh Thuy Nguyen, Naomi Hall, Dylan Sheerin, Michael Carr, Cillian F De Gascun, the Irish Hepatitis C Outcomes Research Network

Antiviral Therapy 2016; 21:447-453


Short communication

Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16INK4a expression in subjects on combination therapy

Julie B Dumond, Owen Francis, Mackenzie Cottrell, Christine Trezza, Heather MA Prince, Katie Mollan, Craig Sykes, Chad Torrice, Nicole White, Stephanie Malone, Ruili Wang, Cornelius Van Dam, Kristine B Patterson, Michael G Hudgens, Norman E Sharpless, Alan Forrest

Antiviral Therapy 2016; 21:441-445


Short communication

Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy

Patumrat Sripan, Sophie Le Coeur, Lily Ingsrisawang, Tim R Cressey, Naïm Bouazza, Frantz Foissac, Nicole Ngo-Giang-Huong, Patrinee Traisathit, Ussanee Srirompotong, Orada Patamasingh Na Ayudhaya, Achara Puangsombat, Jantana Jungpipun, Kanokwan Jittayanun, Jean-Marc Tréluyer, Gonzague Jourdain, Marc Lallemant, Saïk Urien

Antiviral Therapy 2016; 21:435-440


Original article

Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

Marianne Martinello, Margaret Hellard, David Shaw, Kathy Petoumenos, Tanya Applegate, Jason Grebely, Barbara Yeung, Laurence Maire, David Iser, Andrew Lloyd, Alexander Thompson, Joe Sasadeusz, Paul Haber, Gregory J Dore, Gail V Matthews

Antiviral Therapy 2016; 21:425-434


Original article

An inception cohort study assessing the role of pneumococcal and other bacterial pathogens in children with influenza and ILI and a clinical decision model for stringent antibiotic use

Franziska Tief, Christian Hoppe, Lea Seeber, Patrick Obermeier, Xi Chen, Katharina Karsch, Susann Mühlhans, Eleni Adamou, Tim Conrad, Ariel Beresniak, Brunhilde Schweiger, Thomas Adam, Barbara Rath

Antiviral Therapy 2016; 21:413-424


Original article

Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons

Vincent Calvez, Anne-Genevieve Marcelin, Johan Vingerhoets, Andrew Hill, Blanca Hadacek, Christiane Moecklinghoff

Antiviral Therapy 2016; 21:405-412


Page:
Copyright © Nucleus Global 2016. Part of Nucleus Global.
Design and Technology by Nucleus Global
Company registration No. 321 0712 (England & Wales). Registered Office address: Admiral House 76-78 Old Street, London EC1V 9AZ.